Forward focused thinking

Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.

Explore our ideas and get a deeper understanding of the current and future trends in healthcare:


Are reverse auctions the best way to procure marketing services?

Martin Brass | 6th October 2016

Managing Director Martin Brass discusses what a reverse auction is, and whether it truly is a good way for healthcare companies to drive efficiencies when procuring marketing services.

read more


Are we harnessing the full emotional power of brand creativity?

Damien Parsonage | 30th September 2016

Creative Director Damien Parsonage breaks down the common misconception that pharma and healthcare marketing for healthcare professionals ought to be entirely scientific and rational. Brands are powerful; here's how to strengthen yours by infusing it with emotion.

read more


Artificial Intelligence: the new healthcare algorithm

Kulveer Singh | 26th September 2016

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare. Associate Medical Copywriter Kulveer Singh dives deeper into the technology.

read more


Marketing strategy in complex environments

Mark Assenti, Kulveer Singh | 19th September 2016

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines.

read more


DAM and CMS: managing assets to maximise adoption and value

David Wood | 14th September 2016

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.

read more

Is fear an effective driver for behaviour change?

Is fear an effective driver of behaviour change?

Natalie Seebeck | 4th September 2016

Client Lead Natalie Seebeck explains that applying fear-based models in communications can be effective, if the right components are used in the right way.

read more

Alzheimer's Disease eeviewing the immediate treatment horizon

Alzheimer’s disease: reviewing the immediate treatment horizon

Stuart Goodman | 2nd September 2016

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

read more


A stumble, but not a fall – what’s next for Opdivo?

Louis Perdios | 24th August 2016

In this article, Associate Consultant Louis Perdios talks about the immunotherapy drug Opdivo and the daunting challenges faced by BMS after disappointing results. However the future for Opdivo may not be as bleak as it seems. 


read more


Immuno-oncology; bringing patients closer to treatment

Frances Hendry, Zoe Bartley | 18th August 2016

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment? Even more importantly, what do immunotherapies mean for patients who face diagnosis of advanced cancers? Senior Associate Consultants Frances Hendry and Zoe Bartley tackle these complex questions.

read more


The biofuel cell – breathing new life into portable electronics?

Kulveer Singh | 16th August 2016

Associate Medical Copywriter Kulveer Singh explains how biofuel cells work, why they are an exciting alternative to normal battery power, and what the challenges are in implementing their use.

read more